132 related articles for article (PubMed ID: 9264567)
1. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.
Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C
Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
3. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
[TBL] [Abstract][Full Text] [Related]
6. BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma.
Ter Harmsel B; Smedts F; Kuijpers J; Jeunink M; Trimbos B; Ramaekers F
J Pathol; 1996 May; 179(1):26-30. PubMed ID: 8691340
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of granzyme B and vascular endothelial growth factor (VEGF) in normal uterine cervices and low and high grade squamous intraepithelial lesions.
Belfort-Mattos PN; Focchi GR; Speck NM; Taha NS; Carvalho CR; Ribalta JC
Eur J Gynaecol Oncol; 2010; 31(4):459-61. PubMed ID: 20882896
[TBL] [Abstract][Full Text] [Related]
8. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions.
McCluggage WG; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1998 Jan; 17(1):29-35. PubMed ID: 9475189
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of lectin-receptors in normal, dysplastic and neoplastic cervical epithelium].
Li ZH
Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):284-7. PubMed ID: 1813164
[TBL] [Abstract][Full Text] [Related]
12. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
13. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer.
Zhou JH; Chen HZ; Ye F; Lu WG; Xie X
Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of filaggrin in benign, premalignant and malignant cervical tissue.
Lara C; Serra V; Marzo C; Valcuende F; Castells A; Bonilla-Musoles FM
Arch Gynecol Obstet; 1994; 255(2):73-9. PubMed ID: 8092889
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia.
Dellas A; Schultheiss E; Almendral AC; Torhost J; Gudat F
Gynecol Oncol; 1996 Aug; 62(2):218-25. PubMed ID: 8751553
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix.
Inki P; Stenbäck F; Grenman S; Jalkanen M
J Pathol; 1994 Apr; 172(4):349-55. PubMed ID: 8207616
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
18. [CD44 splice variants as prognostic factors in invasive cervix carcinoma].
Reinthaller A; Kainz C; Kohlberger P; Tempfer C; Gitsch G; Kölbl H; Breitenecker G
Gynakol Geburtshilfliche Rundsch; 1995; 35(1):16-9. PubMed ID: 7537136
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
20. CD44 is a marker of endocervical neoplasia.
Ibrahim EM; Blackett AD; Tidy JA; Wells M
Int J Gynecol Pathol; 1999 Apr; 18(2):101-8. PubMed ID: 10202665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
